Selective Stalling of Human Translation by Small Molecules
小分子对人类翻译的选择性停滞
基本信息
- 批准号:10004692
- 负责人:
- 金额:$ 29.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:Amino Acid SequenceAmino Acid SubstitutionAmino AcidsBackBehaviorBindingBiochemicalBiological AssayCRISPR interferenceCellsClinicComplexCryoelectron MicroscopyDNA-Protein InteractionDataDevelopmentDiseaseDrug TargetingEffectivenessEscherichia coliExhibitsFRAP1 geneFamilyFoundationsFutureG protein coupled receptor kinaseGeneticHumanLibrariesMapsMessenger RNAModelingMolecularMutationNonsense CodonNucleotidesPathway interactionsPeptide Initiation FactorsPharmaceutical PreparationsPlayProtein FamilyProteinsProteomeQuality ControlRNA, Ribosomal, 23SReporterResolutionRibosomal ProteinsRibosomal RNARibosomesRoleSignal PathwayStructural ModelsStructureSystemTechnologyTestingTherapeuticTranslation InitiationTranslationsViral ProteinsVirusbasedrug candidateguided inquiryhuman diseaseinsightinterestmulticatalytic endopeptidase complexoverexpressionpolypeptidepreventprotein complexprotein degradationreconstitutionribosome profilingsmall moleculetherapeutic developmenttranscription factortranslation to humans
项目摘要
ABSTRACT
Protein targets for many human diseases remain “undruggable” due to their underlying biochemical behavior.
These limits to discovery of small molecule drugs hold back the promise of developing affordable therapeutics.
Here we propose to develop an entirely new mechanism of action that could enable targeting previously
“undruggable” proteins, by selectively blocking their translation by the human ribosome. Most drugs and drug
candidates known to modulate human translation target translation initiation factor complexes or upstream
signaling pathways such as mammalian target of Rapamycin (mTOR). These generally modulate translation of
a large number of mRNAs. To date, only one type of compound that selectively targets the ribosome–to induce
premature stop codon readthrough–is being evaluated in the clinic. We recently demonstrated that small
molecules can selectively stall the translation of human proteins, with very little off-target activity. The
compound we analyzed, PF-06446846 (PF846), directly and selectively inhibits the translation of PCSK9
during translation elongation, by stalling the ribosome on the nascent polypeptide residing in the ribosome exit
tunnel. However, it remains unclear how this and related compounds selectively stall translation. The few
examples of off-target proteins we identified as stalled by PF846 (less than 0.4 percent of the human
proteome) exhibit substantial primary structure variability, making it difficult to predict target sequences for
future development of selective ribosome-targeting drugs. We have preliminary evidence that PF846 interacts
with these diverse nascent chain sequences to induce ribosome stalling by subtly different mechanisms. We
propose to elucidate the full molecular mechanism of PF846 stalling of translation, so that this family of
compounds can be further optimized to target proteins whose expression or overexpression causes diverse
human diseases for which no treatments are now available. This family of compounds could also be optimized
to target viruses, which use human translation to synthesize their proteome. These efforts have the potential to
open up an entirely new mechanism of action for human therapeutic development.
摘要
许多人类疾病的蛋白质靶标由于其潜在的生化行为而仍然是“无法下药的”。
发现小分子药物的这些限制阻碍了开发负担得起的疗法的希望。
在这里,我们建议开发一种全新的行动机制,它可以使以前的目标
“不能下药的”蛋白质,通过选择性地阻止人类核糖体的翻译。大多数药物和药物
已知可调节人类翻译靶向翻译起始因子复合体或上游的候选
哺乳动物雷帕霉素靶标(MTOR)等信号通路。这些通常调整翻译的
大量的mRNA。到目前为止,只有一种类型的化合物选择性地靶向核糖体-诱导
提前终止密码子通读-正在临床上进行评估。我们最近展示了一个小的
分子可以选择性地拖延人类蛋白质的翻译,几乎没有偏离目标的活性。这个
我们分析的化合物PF-06446846(PF846)直接和选择性地抑制PCSK9的翻译
在翻译延伸过程中,通过使位于核糖体出口的新生多肽上的核糖体停滞
隧道。然而,目前还不清楚这种化合物和相关化合物是如何选择性地阻碍翻译的。为数不多的
我们发现的被PF846抑制的脱靶蛋白的例子(不到人类的0.4%
蛋白质组)表现出很大的一级结构变异性,使得预测目标序列变得困难
选择性核糖体靶向药物的未来发展。我们有初步证据表明,PF846与
这些不同的新生链序列通过微妙的不同机制诱导核糖体停滞。我们
建议阐明PF846翻译停滞的全分子机制,从而使这一家族
化合物可以进一步优化以靶向其表达或过度表达导致不同
目前尚无治疗方法的人类疾病。这一系列化合物也可以进行优化
以病毒为目标,这些病毒使用人类翻译来合成它们的蛋白质组。这些努力有可能
为人类治疗发展开辟了一种全新的作用机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMIE H CATE其他文献
JAMIE H CATE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMIE H CATE', 18)}}的其他基金
Selective Stalling of Human Translation by Small Molecules
小分子对人类翻译的选择性停滞
- 批准号:
10443568 - 财政年份:2019
- 资助金额:
$ 29.59万 - 项目类别:
Selective Stalling of Human Translation by Small Molecules
小分子对人类翻译的选择性停滞
- 批准号:
10194545 - 财政年份:2019
- 资助金额:
$ 29.59万 - 项目类别:
STRUCTURES OF THE E COLI 70S RIBOSOME IN FUNCTIONAL COMPLEXES
功能复合物中大肠杆菌 70S 核糖体的结构
- 批准号:
7954332 - 财政年份:2009
- 资助金额:
$ 29.59万 - 项目类别:
STRUCTURES OF THE E COLI 70S RIBOSOME IN FUNCTIONAL COMPLEXES
功能复合物中大肠杆菌 70S 核糖体的结构
- 批准号:
7721984 - 财政年份:2008
- 资助金额:
$ 29.59万 - 项目类别:
相似海外基金
Phenotypic consequences of a modern human-specific amino acid substitution in ADSL
ADSL 中现代人类特异性氨基酸取代的表型后果
- 批准号:
24K18167 - 财政年份:2024
- 资助金额:
$ 29.59万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Estimation of stability and functional changes due to amino acid substitution using molecular simulations
使用分子模拟估计氨基酸取代引起的稳定性和功能变化
- 批准号:
20H03230 - 财政年份:2020
- 资助金额:
$ 29.59万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the mechanisms of prion protein conversion caused by an amino acid substitution in glycosylphosphatidylinositol anchoring signal peptide
阐明糖基磷脂酰肌醇锚定信号肽中氨基酸取代引起的朊病毒蛋白转化机制
- 批准号:
16K18790 - 财政年份:2016
- 资助金额:
$ 29.59万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Amino acid substitution without genetic modification
无需基因改造的氨基酸替代
- 批准号:
15H05491 - 财政年份:2015
- 资助金额:
$ 29.59万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Study on PSII hydrogen bond networks by exhaustive amino acid substitution
穷举氨基酸取代研究PSII氢键网络
- 批准号:
15K07110 - 财政年份:2015
- 资助金额:
$ 29.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the effect of HCV propagationa and IFN sensitivity by amino acid substitution in interferon sensitivity-determining region.
阐明干扰素敏感性决定区氨基酸取代对 HCV 传播和干扰素敏感性的影响。
- 批准号:
26860309 - 财政年份:2014
- 资助金额:
$ 29.59万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The analysis of the restriction of amino acid substitution on the hemagglutinin molecule of influenza A virus
甲型流感病毒血凝素分子氨基酸取代限制性分析
- 批准号:
14370104 - 财政年份:2002
- 资助金额:
$ 29.59万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Changes in the Substrate Specificities of Farnesyl Diphosphate Synthase by a Single Amino Acid Substitution
单一氨基酸取代对法尼基二磷酸合酶底物特异性的变化
- 批准号:
12680587 - 财政年份:2000
- 资助金额:
$ 29.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analyses of the Relationship between Amino Acid Substitution and Phenotype of the Tail Sheath Protein of Bacteriophage T4
噬菌体T4尾鞘蛋白氨基酸取代与表型关系分析
- 批准号:
02680125 - 财政年份:1990
- 资助金额:
$ 29.59万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Hypothesis: Both appearance and disappearance of viruses are controlled by the accumulation of amino acid substitution in receptor binding domain
假设:病毒的出现和消失都是由受体结合域氨基酸取代的积累控制的
- 批准号:
02454184 - 财政年份:1990
- 资助金额:
$ 29.59万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)